You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Microsoft launches a module that converts Word documents into XML format for database archiving.
It's not looking good for Pfizer and its attempts to force journals to turn over the names of peer reviewers -- and that's making a lot of scientists very happy.
This week's Nature reports on iPS cells, hematopoietic stem cells, translation, and more.
Alnylam's John Maraganore pens an op-ed piece in the Boston Globe about threats to biomedical patents.
Researchers map methylation changes across many cancer types.
A blogger comments on opening up the TAIR database to the community.
This week's PLoS Biology includes a consensus statement on ethics in whole-genome research.
Up next for 23andMe customers: social networking based on DNA.
Bloggers discuss structuring data.
Personalized medicine in WSJ, but are consumers ready?
Bloggers discuss the function of Lin-28, let7 in stem cells and cancer.
A blogger works on his HapCluster association mapping software.
The Washington Post reports that a stolen laptop contained unencrypted data from patients in clinical trials.
Researchers use computational analyis to predict regulatory networks in macrophage activation.
A blogger lists the emotions that go along with writing a thesis.
A blogger reports on a new Texas law requiring insurers to give employers access to their employees' medical records.
The red flour beetle gets its genome sequenced.
Scientists develop vector signatures to identify engineered bacteria.
DNA sampling is being used to identify victims of an Argentine dictatorship.
Science this week looks at structural biology, genetic causes of ALS and non-Hodgkin's lymphoma, and more.
Navigenics will kick off its genomics service next month in New York City.
Wall Street Journal covers human variation and genome-wide association studies.
A blogger uses the RSS feed concept to keep track of his research activity, paper bibliography, and more.
The European Journal of Human Genetics has an editorial about recreational genomics.
A small tech company offers a $1 million prize to programmers for building apps for its natural-language processing tool.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.